We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > volanesorsen

News List

NICE issues draft guidance, finding negative opinion for volanesorsen europeanpharmaceuticalreview
January 06, 2020
Waylivra (volanesorsen) has not been recommended for treatment of familial chylomicronaemia syndrome, according to draft guidance from NICE.
UK patients get early access to Akcea’s volanesorsen pharmatimes
July 20, 2018
Akcea Therapeutics’ volanesorsen will be available to eligible patients in the UK before it is officially licensed in the EU, having been granted entry to the country’s Early Access to Medicines Scheme.
Ionis spinout Akcea files for approval of volanesorsen fiercebiotech
September 05, 2017
Akcea Therapeutics has filed for FDA approval of volanesorsen. The Ionis Pharmaceuticals spinout sees the filing positioning it to bring the treatment of familial chylomicronemia syndrome (FCS) to market in the U.S. next year.